Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

View:
Post by TitanTrader on Mar 07, 2019 3:49pm

News

INVICTUS AND CANNAMERICA PROVIDE UPDATE ON HEMP AND CBD JOINT VENTURE Vancouver, BC, March 07, 2019 (GLOBE NEWSWIRE) -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to provide an update on its binding letter of intent to create a joint venture with Cannamerica Brands Corp. (CSE: CANA) (OTCQB: CNNXF) and CBDistribution Company Ltd. (collectively, the Joint Venture) that was previously announced on January 7, 2019, with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction. The transaction is anticipated to close on or before March 31, 2019. Each of the parties involved have received approval from their respective Board of Directors to enter into the Joint Venture. Once the transaction is closed, the Joint Venture will mark the Companys entry into the CBD market in the United States. The Joint Venture will no longer be purchasing eighty percent (80%) of the membership interests of Z3 Sciences, LLC, as previously announced on January 16, 2019, due to a mutual decision made by all parties involved. Invictus has also granted 450,000 incentive stock options to certain consultants of the Company. Each stock option has an exercise price of $0.95 and is exercisable into one common share of the Company. The options vest immediately and are exercisable over a period of five years. The stock options were granted subject to the terms and conditions of the Companys Stock Option Plan. For more information, please visit www.invictus-md.com. On Behalf of the Board, George E. Kveton Chief Executive Officer and Director Jessica Martin Vice President, Public Relations and Regulatory Affairs (833) 879-4363
Comment by RaduBiris on Mar 07, 2019 5:40pm
it looks like we are going back to $1.20 area.. US market is huge!
Comment by Eoj123 on Mar 07, 2019 7:18pm
I'm a bit uncertain how the 3 way jv will function but I guess if they are not buying the 80% then they won't need to spend / raise $45 million. (if my memory of the deal is correct)??
Comment by display_name on Mar 08, 2019 6:10pm
Probably a net benefit? Idk without revised conditions being stated it's tough to say but I'd expect them not spending 42 mil to be a positive? I'd like to hear what is happening to the incentive goals whuh were laid put for Z3 on the assumption of partial ownership by the JV partner's. Im hoping those are being scrapped in favor of some more straightforward cost and revenue ...more  
Comment by StockTakers on Mar 08, 2019 6:28pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities